4.2 Article

Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Virology

Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies

Marie Tre-Hardy et al.

Summary: The study assessed the performance of two ELISA tests for detecting antibodies against SARS-CoV-2 nucleocapsid protein, showing satisfactory analytical performance and excellent clinical performance for IgG, IgA, and total antibodies, especially with optimized cut-offs.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Medicine, General & Internal

Racial and ethnic disparities in viral acute respiratory infections in the United States: protocol of a systematic review

Neia Prata Menezes et al.

Summary: The COVID-19 pandemic has exposed consistent inequities in incidence, disease severity, and mortality across racial and ethnic minority populations, prompting a systematic review to comprehensively document disparities in viral acute respiratory infections other than SARS-CoV-2. This review aims to understand the structural health and social factors driving these disparities and ultimately support pandemic preparedness and improved responses to future viral respiratory pathogens.

SYSTEMATIC REVIEWS (2021)

Article Medical Laboratory Technology

Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2

Eric J. Nilles et al.

Summary: This study evaluated the performance of 5 different immunoassays for detecting prior infection with SARS-CoV-2, with Roche assay showing the highest specificity and Simoa immunoassay demonstrating the highest sensitivity across different days post-symptom onset.

JOURNAL OF APPLIED LABORATORY MEDICINE (2021)

Article Medical Laboratory Technology

SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses

Raymond T. Suhandynata et al.

Summary: The study assessed the clinical performance of four commercial SARS-CoV-2 serology platforms in detecting infection or vaccination, finding that Roche S-antibody and Diazyme NAbs assays robustly detected adaptive immune responses. On the other hand, Roche N-antibody and Diazyme IgG assays did not detect adaptive immune response. Diazyme NAbs assay showed a strong correlation with PSV SARS-CoV-2 NAbs in vaccinated individuals.

JOURNAL OF APPLIED LABORATORY MEDICINE (2021)

Article Public, Environmental & Occupational Health

SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria

Olatunde Olayanju et al.

Summary: Despite the predicted high magnitude of the pandemic in Africa due to poor health structures and living conditions, surprisingly, a study in a hospital in Nigeria found a high seroprevalence of SARS-CoV-2 among frontline health workers, indicating the need for stricter precautions within the hospital environment.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)

Article Biophysics

Dual lateral flow optical/chemiluminescence immunosensors for the rapid detection of salivary and serum IgA in patients with COVID-19 disease

Aldo Roda et al.

Summary: The study developed a noninvasive and highly sensitive immunosensor for IgA in saliva and serum, which can be used for diagnosing and monitoring COVID-19 infection. The immunosensor demonstrated the capability to detect salivary IgA in infected individuals and correlated with disease severity and infection time.

BIOSENSORS & BIOELECTRONICS (2021)

Review Biochemistry & Molecular Biology

Adaptive immunity to SARS-CoV-2 and COVID-19

Alessandro Sette et al.

Summary: The adaptive immune system, consisting of B cells, CD4(+) T cells, and CD8(+) T cells, plays varying roles in different viral infections and vaccines. Studies are showing that CD4(+) T cells, CD8(+) T cells, and neutralizing antibodies all play a part in controlling SARS-CoV-2 in COVID-19 cases, emphasizing the importance of understanding adaptive immunity in combating the disease.
Article Biotechnology & Applied Microbiology

Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies

Myriam C. Weber et al.

Summary: The study evaluated the performance of three widely used SARS-CoV-2 antibody testing platforms, showing that all three assays had high sensitivity and specificity at the manufacturers' recommended cut-offs, with ECLIA having higher positive predictive value at low pretest probabilities.

DISEASE MARKERS (2021)

Article Infectious Diseases

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020

Kathy Leung et al.

Summary: Two new lineages of SARS-CoV-2 with the N501Y mutation in the receptor-binding domain of the spike protein have spread rapidly in the United Kingdom. The 501Y lineage without amino acid deletion Delta 69/Delta 70 was estimated to be 10% more transmissible than the 501N lineage, while the 501Y lineage with amino acid deletion Delta 69/Delta 70 was estimated to be 75% more transmissible than the 501N lineage.

EUROSURVEILLANCE (2021)

Editorial Material Immunology

T Cell Memory: Understanding COVID-19

Nicholas N. Jarjour et al.

Summary: This primer discusses the fundamental features of T cell memory and their potential relevance for effective immunity to SARS-CoV-2, as the focus shifts towards establishing natural and vaccine-induced immunity against COVID-19.

IMMUNITY (2021)

Article Infectious Diseases

High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo

Armel Landry Batchi-Bouyou et al.

Summary: The Republic of the Congo conducted a seroprevalence study on healthy individuals to evaluate the incidence of SARS-CoV-2, finding a certain proportion testing positive for the virus. Among RT-PCR negative subjects, the seroprevalence of IgG and IgM antibodies increased over time, with higher rates in women compared to men.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Immunology

Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco

Genay Pilarowski et al.

Summary: The study evaluated the performance of the rapid antigen test for COVID-19 and found that at a specific threshold, the test had high sensitivity and specificity, making it suitable for asymptomatic individuals.

JOURNAL OF INFECTIOUS DISEASES (2021)

Editorial Material Virology

Guidelines on newly identified limitations of diagnostic tools for COVID-19 and consequences

Kirtimaan Syal

Summary: COVID-19, caused by coronavirus, has become the deadliest pandemic of the 21st century due to its rapid global spread. Timely diagnosis is critical, but current diagnostic methods are limited by high error rates, cost, and other factors, posing risks to patient care and population control efforts.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Letter Medicine, General & Internal

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

Alicia T. Widge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Medicine, General & Internal

Recommendations for SARS-CoV-2/COVID-19 testing: a scoping review of current guidance

Ingrid Arevalo-Rodriguez et al.

Summary: This research compiled and assessed global recommendations on COVID-19 testing, highlighting limitations in the methodological quality of included guidance documents that may impact clinician confidence. Future guidance should incorporate key methodological characteristics to improve decision-making applicability.

BMJ OPEN (2021)

Article Medicine, General & Internal

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

Kristina L. Bajema et al.

Summary: This cross-sectional study indicates that as of September 2020, most people in the US did not have serologic evidence of previous SARS-CoV-2 infection, although the prevalence varied widely by jurisdiction. Seroprevalence surveys showed variations in infection rates between different sexes, age groups, and metropolitan/nonmetropolitan areas.

JAMA INTERNAL MEDICINE (2021)

Article Public, Environmental & Occupational Health

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021

Summer E. Galloway et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Biophysics

Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer

Naveen K. Singh et al.

Summary: The study introduces an aptamer-based SARS-CoV-2 salivary antigen assay that utilizes low-cost reagents and an off-the-shelf glucometer. This test is highly scalable, provides rapid results within 1 hour, and can accurately detect viral loads in infected specimens while distinguishing them from uninfected controls.

BIOSENSORS & BIOELECTRONICS (2021)

Article Biochemistry & Molecular Biology

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Wanwisa Dejnirattisai et al.

Summary: Antibodies play a crucial role in immune protection against SARS-CoV-2, with some being used as therapeutics. A study identified 377 human monoclonal antibodies, focusing on 80 that bind the virus spike, and found that most highly inhibitory antibodies can block the virus-receptor interaction. Novel binding modes of potent inhibitory antibodies were discovered, showing potential for prophylactic or therapeutic use in animal models.
Article Biochemistry & Molecular Biology

Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection

Elizabeth M. Anderson et al.

Summary: Our research indicates that most individuals had antibodies against other seasonal human coronaviruses before the COVID-19 pandemic. Around 20% of these individuals also had antibodies that cross-reacted with SARS-CoV-2, but these antibodies did not offer protection against SARS-CoV-2 infections or hospitalizations.
Review Infectious Diseases

Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis

Mona Mustafa Hellou et al.

Summary: This study evaluated the diagnostic test accuracy of nucleic acid amplification tests (NAATs) for coronavirus infections and found that real-time RT-PCR assays have higher sensitivity. The pooled results indicated that on average 10% of patients with coronavirus infections might be missed with PCR tests.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Review Respiratory System

COVID-19 new diagnostics development: novel detection methods for SARS-CoV-2 infection and considerations for their translation to routine use

Jim F. Huggett et al.

Summary: The review highlights the urgent need for accurate SARS-CoV-2 tests and discusses the development of various analytical tools in response to the global demand. It emphasizes the importance of reproducibility and fitness for purpose for novel diagnostic solutions to succeed in widespread clinical and surveillance applications.

CURRENT OPINION IN PULMONARY MEDICINE (2021)

Article Infectious Diseases

Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended use

Anna Christine Nilsson et al.

Summary: This study evaluated six commercial serological assays for detection of SARS-CoV-2 antibodies, finding that ELISA assays are most suitable for mild cases, while Livzon LFT and Euroimmun ELISA have the highest specificity, making them suitable for seroprevalence studies.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Microbiology

Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts

Nira R. Pollock et al.

Summary: The study evaluated the performance of the Abbott BinaxNOW COVID-19 Ag card in a community testing site and found high sensitivity in newly symptomatic adults, but lower sensitivity in children and asymptomatic individuals, revealing potential limitations of the BinaxNOW test.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Article Microbiology

Evaluation of Specimen Types and Saliva Stabilization Solutions for SARS-CoV-2 Testing

Sara B. Griesemer et al.

Summary: Identifying SARS-CoV-2 infections through aggressive diagnostic testing is crucial in tracking and controlling the spread of COVID-19. Alternative specimen types like nasal swabs and saliva have been investigated for detection sensitivity, with combining the two sample types resulting in improved sensitivity. Additionally, stabilizing solutions did not enhance virus stability in saliva.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Article Virology

Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?

Tuna Toptan et al.

Summary: The study evaluated the sensitivity and specificity of a newly licensed rapid antigen test for SARS-CoV-2, showing its effectiveness in detecting infectious patients. The antigen test was found to have no cross-reactivity against other common respiratory viruses and demonstrated reliable performance.

JOURNAL OF CLINICAL VIROLOGY (2021)

Article Biochemistry & Molecular Biology

Variation in SARS-CoV-2 outbreaks across sub-Saharan Africa

Benjamin L. Rice et al.

Summary: The SARS-CoV-2 pandemic has shown low burdens in sub-Saharan Africa compared to other regions, potentially influenced by factors such as climate and population demographics. Caution is needed when interpreting analyses that aggregate data from low- and middle-income settings. Heterogeneity in connectivity across sub-Saharan Africa may contribute to variance in the pace of viral spread.

NATURE MEDICINE (2021)

Article Biochemistry & Molecular Biology

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Rita E. Chen et al.

Summary: The study analyzed antibody neutralization activity against a panel of authentic isolates and chimeric SARS-CoV-2 variants, showing significantly reduced neutralizing activity against the B.1.351 variant first identified in South Africa. Antibodies targeting the receptor-binding domain and N-terminal domain, monoclonal antibodies, convalescent sera, and mRNA vaccine-induced immune sera exhibited decreased inhibitory activity against viruses with an E484K spike mutation, suggesting a need for updated monoclonal antibodies or vaccine adjustments to prevent loss of protection against emerging variants.

NATURE MEDICINE (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Constantinos Kurt Wibmer et al.

Summary: The SARS-CoV-2 virus in the B.1.351 variant discovered in South Africa can evade neutralization by most antibodies when expressed, but does not affect binding by convalescent plasma. This suggests the potential for reinfection with antigenically distinct variants and predicts reduced efficacy of spike-based vaccines.

NATURE MEDICINE (2021)

Article Multidisciplinary Sciences

Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa

Jane Alexandra Shaw et al.

Summary: In Cape Town, South Africa, there is a high seroprevalence of SARS-CoV-2 antibodies, particularly among those of lower socioeconomic status. Nearly half of cases are asymptomatic, with seropositivity being significantly associated with living conditions, low-income areas, and low-paying occupations.

PLOS ONE (2021)

Review Chemistry, Analytical

Technical considerations to development of serological tests for SARS-CoV-2

Emilie Ernst et al.

Summary: The COVID-19 pandemic has led to increased focus on clinical assays, particularly serological testing, to assess exposure to SARS-CoV-2 and immune response to the virus and vaccines. While some tests faced quality issues, they still contribute to public health efforts, highlighting challenges for both emerging technologies and established platforms.

TALANTA (2021)

Article Chemistry, Analytical

A multi-target lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2

Simone Cavalera et al.

Summary: This new rapid test can accurately detect the total antibody response to SARS CoV-2 infection, with high diagnostic specificity and sensitivity, and can detect infection earlier.

TALANTA (2021)

Article Infectious Diseases

Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies

Anja Garritsen et al.

Summary: Serological testing during the COVID-19 pandemic provides sero-epidemiological data and can retrospectively inform about suspected SARS-CoV-2 infection. A two-tiered testing strategy combining a RBD-specific LFA with a NCP IgG ELISA was effective in assessing seroconversion in individuals. Results showed high specificity of serology testing and the sVNT proved to be a valuable tool for SARS-CoV-2 transmission dynamics modeling.

INFECTIOUS DISEASES (2021)

Article Medicine, Research & Experimental

Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2

Krystle K. Q. Yu et al.

Summary: The study found that comorbid medical illnesses reduce the coordinated response between T cells and antibodies targeting SARS-CoV-2 in COVID-19 patients, leading to more severe disease outcomes.

JCI INSIGHT (2021)

Article Medicine, General & Internal

Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia

Elizabeth T. Rogawski McQuade et al.

Summary: This statewide study in Virginia found that 2.4% of adults had been exposed to SARS-CoV-2, significantly higher among Hispanic individuals, those living in multifamily units, and those in contact with confirmed COVID-19 cases. Most infections were asymptomatic, indicating a largely immunologically naive population in Virginia as of August 2020.

JAMA NETWORK OPEN (2021)

Article Infectious Diseases

Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan

Muhammad Imran Nisar et al.

Summary: This study conducted three cross-sectional surveys in Karachi, Pakistan, revealing different seroprevalence rates of COVID-19 in various areas and highlighting the prevalence of asymptomatic infections. Ongoing seroprevalence studies will contribute to a better understanding of the trends and extent of infection during the pandemic.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Virology

Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures

Verena Haage et al.

Summary: This study assessed the analytical sensitivity and specificity of eleven commercially-available SARS-CoV-2 Ag-RDTs under different storage and operational temperatures, finding that elevated temperatures impair sensitivity while low temperatures impair specificity. Recommended storage and operation conditions are essential for successful usage of SARS-CoV-2 Ag-RDTs during the pandemic.

JOURNAL OF CLINICAL VIROLOGY (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 integral membrane proteins shape the serological responses of patients with COVID-19

Sophie Martin et al.

Summary: The SARS-CoV-2 pandemic has prompted the scientific community to develop tools to combat the infection by studying the immunogenic potential of viral proteins S, E, and M. Patients with moderate to severe diseases exhibit elevated Ig responses against these proteins, with reduced Ig binding observed with the spike G614 variant compared to the D614 variant. This research represents a powerful tool to test humoral responses against evolving SARS-CoV-2 variants and vaccine effectiveness.

ISCIENCE (2021)

News Item Multidisciplinary Sciences

Five reasons why COVID herd immunity is probably impossible

Christie Aschwanden

Summary: Despite vaccination efforts in full force, the theoretical threshold for conquering COVID-19 appears to be unattainable.

NATURE (2021)

Editorial Material Medicine, General & Internal

What do we know about India's Covaxin vaccine?

Kamala Thiagarajan

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Infectious Diseases

Impact of the Covid-19 epidemic and related social distancing regulations on social contact and SARS-CoV-2 transmission potential in rural South Africa: analysis of repeated cross-sectional surveys

Nicky McCreesh et al.

Summary: After South Africa implemented strict social distancing regulations, social contacts in rural areas decreased significantly, especially in other people's homes and public spaces. Older adults had fewer interactions with those over 50, but their interactions with 15-29 year olds remained relatively stable.

BMC INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2

Bianca A. Trombetta et al.

Summary: The study evaluated the accuracy of 20 IgG and IgM assays for detecting SARS-CoV-2 antibodies, and developed a user-friendly web app to extrapolate positive predictive values based on accuracy and local prevalence. The lateral flow assays showed a range of sensitivities and specificities, with potential for home testing and monitoring disease prevalence.

BMC INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants

Meng Yuan et al.

Summary: Mutations in the RBS residues of new variant strains of the coronavirus can affect the binding and neutralizing effects of antibodies, but have little impact on antibodies targeting more conserved neutralizing sites.

SCIENCE (2021)

Article Immunology

Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020

Kirsten E. Wiens et al.

Summary: A study conducted in Juba, South Sudan found that approximately 38.3% of the population had been infected with SARS-CoV-2, with unreported infections likely being much higher than reported cases. Additionally, differences in background reactivity were observed between Juba and Boston, Massachusetts, where the immunoassay was validated.

EMERGING INFECTIOUS DISEASES (2021)

Letter Immunology

Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy

Fabrizio Maggi et al.

Summary: This case is an imported one where an asymptomatic traveler arrived in Italy and tested positive for the SARS-CoV-2 variant P.1 after traveling indirectly from Brazil, highlighting the risk of introducing SARS-CoV-2 variants through indirect flights and the importance of continued surveillance for SARS-CoV-2.

EMERGING INFECTIOUS DISEASES (2021)

Article Pathology

Practical Considerations for Implementation of SARS-CoV-2 Serological Testing in the Clinical Laboratory: Experience at an Academic Medical Center

Robert M. Humble et al.

Summary: SARS-CoV-2 serology testing plays a limited clinical role at an academic medical center. Clinician concerns mainly revolve around the appropriateness/utility of testing, patient charges/insurance coverage, and assay specificity. Patient interest drove serologic testing in the first month after implementation, but there was little evidence that the results impacted clinical decision-making. Test volumes declined steadily, with inpatient ordering gradually increasing as a percentage of the total.

ACADEMIC PATHOLOGY (2021)

Letter Immunology

Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy

Federica Novazzi et al.

Summary: An imported case of the SARS-CoV-2 variant of concern B.1.1.351 was reported in a 66-year-old symptomatic male who returned from Malawi to Italy.

EMERGING MICROBES & INFECTIONS (2021)

Article Public, Environmental & Occupational Health

High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond?

Carolin Elizabeth George et al.

Summary: People living in urban slums are highly vulnerable to COVID-19 infection and the measures to control its spread. A study in a South Indian slum found a high seroprevalence of COVID-19, with no association with age, education, occupation or comorbidities. The focus should shift from infection prevention to managing the indirect consequences of the pandemic in such settings.

EPIDEMIOLOGY AND INFECTION (2021)

Article Multidisciplinary Sciences

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors

Sophie Uyoga et al.

Summary: The prevalence of anti-SARS-CoV-2 immunoglobulin G among blood donors in Kenya from April to June 2020 was 4.3%, with the highest rates in urban counties like Mombasa, Nairobi, and Kisumu. This suggests that SARS-CoV-2 exposure is more widespread than case-based surveillance indicates.

SCIENCE (2021)

Letter Infectious Diseases

An interactive web-based dashboard to track COVID-19 in real time

Ensheng Dong et al.

LANCET INFECTIOUS DISEASES (2020)

Article Immunology

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Juanjuan Zhao et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Infectious Diseases

Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients

J. Van Elslande et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Article Respiratory System

Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset

Bin Lou et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Editorial Material Medicine, General & Internal

Interpreting Diagnostic Tests for SARS-CoV-2

Nandini Sethuraman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Cell Biology

The outlook for diagnostic purposes of the 2019-novel coronavirus disease

Safa Tahmasebi et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Editorial Material Microbiology

The Role of Antibody Testing for SARS-CoV-2: Is There One?

Elitza S. Theel et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

Article Multidisciplinary Sciences

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Stephen M. Kissler et al.

SCIENCE (2020)

Letter Biology

Detection of serum IgM and IgG for COVID-19 diagnosis

Ling Zhong et al.

SCIENCE CHINA-LIFE SCIENCES (2020)

Article Virology

Genetic variants and source of introduction of SARS-CoV-2 in South America

Julio A. Poterico et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Editorial Material Medicine, General & Internal

Ensuring global access to COVID-19 vaccines

Gavin Yamey et al.

LANCET (2020)

Letter Biotechnology & Applied Microbiology

Diagnostics and the coronavirus: don't let the standards slip

Mark Page et al.

NATURE BIOTECHNOLOGY (2020)

Article Biochemistry & Molecular Biology

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat et al.

NATURE MEDICINE (2020)

Article Biochemistry & Molecular Biology

Antibody responses to SARS-CoV-2 in patients with COVID-19

Quan-Xin Long et al.

NATURE MEDICINE (2020)

Review Medicine, General & Internal

Prevalence of Asymptomatic SARS-CoV-2 Infection A Narrative Review

Daniel P. Oran et al.

ANNALS OF INTERNAL MEDICINE (2020)

Article Medical Laboratory Technology

Measuring the Serologic Response to Severe Acute Respiratory Syndrome Coronavirus 2: Methods and Meaning

Nicole D. Pecora et al.

CLINICS IN LABORATORY MEDICINE (2020)

Review Infectious Diseases

The genetic sequence, origin, and diagnosis of SARS-CoV-2

Huihui Wang et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2020)

Article Biochemistry & Molecular Biology

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Qianqian Li et al.

Review Cell Biology

Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)

Roshan J. D'Cruz et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Virology

Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies

Kathleen G. Beavis et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Article Public, Environmental & Occupational Health

The relatively young and rural population may limit the spread and severity of COVID-19 in Africa: a modelling study

Binta Zahra Diop et al.

BMJ GLOBAL HEALTH (2020)

Article Biochemical Research Methods

SARS-CoV-2-specific ELISA development

Vicky Roy et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2020)

Article Immunology

Racial Disparity of Coronavirus Disease 2019 in African American Communities

Ravina Kullar et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Article Public, Environmental & Occupational Health

SARS-CoV-2 Serosurvey in Addis Ababa, Ethiopia

John H. Kempen et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)

Article Infectious Diseases

Serology testing in the COVID-19 pandemic response

Rosanna W. Peeling et al.

LANCET INFECTIOUS DISEASES (2020)

Letter Infectious Diseases

SeroTracker: a global SARS-CoV-2 seroprevalence dashboard

Rahul K. Arora et al.

LANCET INFECTIOUS DISEASES (2020)

Editorial Material Engineering, Biomedical

Risks of emergency use authorizations for medical products during outbreak situations: a COVID-19 case study

Almir Badnjevic et al.

BIOMEDICAL ENGINEERING ONLINE (2020)

Article Multidisciplinary Sciences

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

Noe B. Mercado et al.

NATURE (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Kizzmekia S. Corbett et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Xin Xu et al.

NATURE MEDICINE (2020)

Letter Medicine, General & Internal

Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19

F. Javier Ibarrondo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Editorial Material Multidisciplinary Sciences

Serology assays to manage COVID-19

Florian Krammer et al.

SCIENCE (2020)

Review Medicine, General & Internal

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis

Mayara Lisboa Bastos et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Immunology

Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?

Saki Takahashi et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Article Immunology

Location Matters: Geographic Disparities and Impact of Coronavirus Disease 2019

Tina Q. Tan et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Article Health Care Sciences & Services

A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy

Lori Ann Post et al.

JOURNAL OF MEDICAL INTERNET RESEARCH (2020)

Article Biotechnology & Applied Microbiology

Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

Jeffrey D. Whitman et al.

NATURE BIOTECHNOLOGY (2020)

Article Engineering, Biomedical

Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19

Maia Norman et al.

NATURE BIOMEDICAL ENGINEERING (2020)

Article Virology

Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?

Francesca Falasca et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Letter Medicine, General & Internal

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

Bina Choi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Antibody profiling and prevalence in US patients during the SARS-CoV2 pandemic

Hari Krishnan Krishnamurthy et al.

PLOS ONE (2020)

Review Multidisciplinary Sciences

Antibody response to SARS-CoV-2 infection in humans: A systematic review

Nathan Post et al.

PLOS ONE (2020)

Article Multidisciplinary Sciences

Serological follow-up of SARS-CoV-2 asymptomatic subjects

Gregorio Paolo Milani et al.

SCIENTIFIC REPORTS (2020)

Article Microbiology

Evaluating ELISA, Immunofluorescence, and Lateral Flow Assay for SARS-CoV-2 Serologic Assays

Moise Michel et al.

FRONTIERS IN MICROBIOLOGY (2020)

Article Public, Environmental & Occupational Health

Analysis of COVID-19 Cases' Spatial Dependence in US Counties Reveals Health Inequalities

T. Saffary et al.

FRONTIERS IN PUBLIC HEALTH (2020)

Review Infectious Diseases

What could explain the late emergence of COVID-19 in Africa?

R. Lalaoui et al.

NEW MICROBES AND NEW INFECTIONS (2020)

Article Immunology

Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG

Gajanan Sapkal et al.

INDIAN JOURNAL OF MEDICAL RESEARCH (2020)

Review Health Care Sciences & Services

A systematic review of the use of the Consolidated Framework for Implementation Research

M. Alexis Kirk et al.

IMPLEMENTATION SCIENCE (2016)

Editorial Material Biochemical Research Methods

POINTS OF SIGNIFICANCE Power and sample size

Martin Krzywinski et al.

NATURE METHODS (2013)

Article Health Policy & Services

Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research Agenda

Enola Proctor et al.

ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH (2011)